Is hospitalization after TIA cost-effective on the basis of treatment with tPA?
other · Level IV
Where this comes from
- Record sourced from PubMed, PMID 16344525.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 24-hour hospitalization for TIA could be cost-effective simply by increasing the likelihood that patients will receive tissue plasminogen activator if a stroke occurs. The authors performed a cost-utility analysis of 24-hour hospitalization for patients diagnosed with recent TIA. The overall cost-effectiveness ratio was 55,044 dollars per quality-adjusted life-year, a value considered borderline cost-effective. For patients with higher risk of stroke, admission was cost-effective.
Medical subject headings
- Fibrinolytic Agents
- Hospitalization
- Ischemic Attack, Transient
- Stroke
- Thrombolytic Therapy
- Tissue Plasminogen Activator